Manila Bulletin
Sinovac COVID vaccine cleared for Phase 3 clinical trials by PH vaccine experts panel
The Philippine Vaccine Expert Panel (VEP), chaired by the Department of Science and Technology, has cleared China's Sinovac COVID-19 vaccine for Phase 3 clinical trials in the country.
However, Sinovac must still receive approval from the Philippines' Ethics Board Committee before it can apply to the Food and Drug Administration (FDA) for clinical trials.
The VEP reviews Phase 1 and 2 clinical trials, while the Ethics Board evaluates participant selection and other safeguards.
FDA Director General Rolando Enrique Domingo stated that Sinovac secured the VEP's clearance on Monday.
If Sinovac secures Ethics Board approval, the FDA's evaluation for its clinical trial application is expected to take 14 to 21 days.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Chinese pharmaceutical company Sinopharm has withdrawn its plan to conduct Phase 3 clinical trials for its COVID-19 vaccine in the Philippines.
Read more →
The Department of Science and Technology (DOST) has started preparations for the COVID-19 vaccine trials in the country.
Read more →
President Rodrigo R. Duterte announced that the Philippines has secured sufficient funds to purchase coronavirus vaccines once they become available.
Read more →
The Department of Trade and Industry (DTI) and the Russian embassy are exploring the possibility of establishing a COVID-19 vaccine plant in the Philippines.
Read more →
The World Health Organization (WHO) is urging the Philippines to increase its commitment to the global COVID-19 vaccine trial by pledging more volunteers.
Read more →